Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study-Reference-Cited by-同舟云学术

Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study

Published:2010-12 Issue:18 Volume:46 Page:3434-3444
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Elsadek Bakheet,Graeser Ralph,Esser Norbert,Schäfer-Obodozie Cynthia,Ajaj Khalid Abu,Unger Clemens,Warnecke André,Saleem Tahia,El-Melegy Nagla,Madkor Hafez,Kratz Felix

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Prostate cancer;Damber;Lancet,2008

2. Modulating paclitaxel bioavailability for targeting prostate cancer;Kumar;Bioorg Med Chem,2007

3. Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancer;Arlen;Future Oncol,2005

4. Prodrug strategies in anticancer chemotherapy;Kratz;ChemMedChem,2008

5. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles;Kratz;J Control Release,2008

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for the development of stimuli-responsive small molecule prodrugs for cancer treatment;Frontiers in Pharmacology;2024-07-31

2. Paclitaxel in breast cancer treatment;Treatment of Breast Cancer with Natural Products;2024

3. Design, synthesis, in silico and biological evaluation of biotin-pyrazole derivatives as anti-cancer activity;Organic Communications;2022-06-28

4. In Vivo Antitumor and Antimetastatic Efficacy of a Polyacetal‐Based Paclitaxel Conjugate for Prostate Cancer Therapy;Advanced Healthcare Materials;2021-11-10

5. Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy;Biochemistry and Biophysics Reports;2021-07